机译:一种新的胰高血糖素类肽-1 / Glucagon受体双激动剂表现出减肥和糖尿病保护作用
Center of Drug Discovery State Key Laboratory of Natural Medicines China Pharmaceutical University;
Center of Drug Discovery State Key Laboratory of Natural Medicines China Pharmaceutical University;
Division of Antitumor Pharmacology Shanghai Institute of Materia Medica Chinese Academy of;
Center of Drug Discovery State Key Laboratory of Natural Medicines China Pharmaceutical University;
Center of Drug Discovery State Key Laboratory of Natural Medicines China Pharmaceutical University;
Center of Drug Discovery State Key Laboratory of Natural Medicines China Pharmaceutical University;
Center of Drug Discovery State Key Laboratory of Natural Medicines China Pharmaceutical University;
Department of Biochemistry and Molecular Biology Nanjing Medical University;
Center of Drug Discovery State Key Laboratory of Natural Medicines China Pharmaceutical University;
Center of Drug Discovery State Key Laboratory of Natural Medicines China Pharmaceutical University;
Glucagon; GLP-1/GCGR agonist; Weight-lowering; Diabetes-protective;
机译:一种新的胰高血糖素类肽-1 / Glucagon受体双激动剂表现出减肥和糖尿病保护作用
机译:双胰高血糖素样肽-1(GLP-1)/胰高血糖素受体Agonist Medi0382改善了小鼠中的纳什的代谢和肝脏指数
机译:一种新的胰高血糖素类肽-1(GLP-1)/胰高血糖素杂化肽,其具有三效式激动剂活性,在葡萄糖依赖性胰岛素多肽,GLP-1和胰高血糖素受体以及高脂肪喂养小鼠的治疗潜力
机译:大“双头配体键”的构象动态:解锁胰高血糖素样肽-1受体信号传导路径
机译:使用互补的多价胰高血糖素样肽-1 /格列苯脲酰胺配体对胰高血糖素样肽-1和磺酰脲-1受体进行联合靶向,以改善β细胞靶向剂和糖尿病治疗。
机译:胰高血糖素样肽1和胰高血糖素样肽1受体激动剂在2型糖尿病的治疗中
机译:胰高血糖素样肽-1受体激动剂和乳腺癌患者糖尿病患者乳腺癌的重量降低